Latest news with #surgicalrobots
BBC News
a day ago
- Health
- BBC News
Robots in Milton Keynes hospital complete 1,000th surgery
A hospital has completed 1,000 surgical procedures using Keynes University Hospital (MKUH) trialled its first robot in November 2019, with a second arriving in October Dr Bot and Dex by local school children, the robots are used by surgeons to carry out a range of colorectal, gynaecological, gastrointestinal, urological and general Barrie Keeler, consultant colorectal surgeon at MKUH, has used the robots frequently and said the 1,000th surgery was a milestone achievement. "Our city is one of the fastest-growing in the country and we have to care for an increasing number of patients every year," he said."Investing in innovative technology, such as the CMR Versius surgical robots, helps us to do that in a safe, effective and timely way." During surgery, experts position the robot at the operating table, where its arms hold instruments and a camera. Inserted through tiny incisions, the robotic arms are controlled by the surgeon from a console with a 3D high definition robots also assist with abdominal wall reconstruction and complex hernia Adnan Qureshi, another consultant colorectal surgeon, praised the technology for how it aids said: "As a surgeon, I benefit from enhanced precision and control, and my patients are typically experiencing reduced complications, faster recovery times and less post-operative pain." Follow Beds, Herts and Bucks news on BBC Sounds, Facebook, Instagram and X.
Yahoo
22-07-2025
- Business
- Yahoo
Intuitive Surgical reports upbeat quarterly earnings on strong demand for surgical robots
(Reuters) -Intuitive Surgical beat Wall Street estimates for second-quarter profit and revenue on Tuesday, driven by growing demand for its surgical robots used in minimally invasive procedures. A steady rise in demand for elective surgeries has contributed to higher procedure volumes for medical device makers such as Intuitive Surgical in recent quarters. The company, known for its da Vinci robotic systems, has seen consistent growth as hospitals work through a backlog of deferred procedures and expand access to minimally invasive care. The medical device maker slightly raised its adjusted gross profit margin forecast for 2025 to between 66% and 67% of revenue, up from earlier estimates of 65% to 66.5%. The updated range includes an estimated impact from tariffs of 1% of revenue, plus or minus 20 basis points, Intuitive said, compared to previously estimated impact of 1.7% of revenue, plus or minus 30 basis points. Shares of the Sunnyvale, California-based company fell 1.5% in after-hours trading. More than 80% of the instruments and accessories for the company's da Vinci system are produced at Intuitive's facility in Mexico, while the company also operates in China and other international markets. Intuitive's worldwide da Vinci procedure volumes rose about 17% compared to the same quarter last year. The company expects global da Vinci-assisted procedures to increase by about 15.5% to 17% in 2025, up from its prior forecast of 15% to 17%. On an adjusted basis, the medical device maker earned $2.19 per share for the quarter ended June 30, beating analysts' estimates of $1.92 per share, according to LSEG data. The company reported revenue of $2.44 billion for the second quarter, compared to analysts' estimates of $2.35 billion. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
22-07-2025
- Business
- Yahoo
Intuitive Surgical reports upbeat quarterly earnings on strong demand for surgical robots
(Reuters) -Intuitive Surgical beat Wall Street estimates for second-quarter profit and revenue on Tuesday, driven by growing demand for its surgical robots used in minimally invasive procedures. A steady rise in demand for elective surgeries has contributed to higher procedure volumes for medical device makers such as Intuitive Surgical in recent quarters. The company, known for its da Vinci robotic systems, has seen consistent growth as hospitals work through a backlog of deferred procedures and expand access to minimally invasive care. The medical device maker slightly raised its adjusted gross profit margin forecast for 2025 to between 66% and 67% of revenue, up from earlier estimates of 65% to 66.5%. The updated range includes an estimated impact from tariffs of 1% of revenue, plus or minus 20 basis points, Intuitive said, compared to previously estimated impact of 1.7% of revenue, plus or minus 30 basis points. Shares of the Sunnyvale, California-based company fell 1.5% in after-hours trading. More than 80% of the instruments and accessories for the company's da Vinci system are produced at Intuitive's facility in Mexico, while the company also operates in China and other international markets. Intuitive's worldwide da Vinci procedure volumes rose about 17% compared to the same quarter last year. The company expects global da Vinci-assisted procedures to increase by about 15.5% to 17% in 2025, up from its prior forecast of 15% to 17%. On an adjusted basis, the medical device maker earned $2.19 per share for the quarter ended June 30, beating analysts' estimates of $1.92 per share, according to LSEG data. The company reported revenue of $2.44 billion for the second quarter, compared to analysts' estimates of $2.35 billion. Sign in to access your portfolio
Reuters
22-07-2025
- Business
- Reuters
Intuitive Surgical reports upbeat quarterly earnings on strong demand for surgical robots
July 22 (Reuters) - Intuitive Surgical (ISRG.O), opens new tab beat Wall Street estimates for second-quarter profit and revenue on Tuesday, driven by growing demand for its surgical robots used in minimally invasive procedures. A steady rise in demand for elective surgeries has contributed to higher procedure volumes for medical device makers such as Intuitive Surgical in recent quarters. The company, known for its da Vinci robotic systems, has seen consistent growth as hospitals work through a backlog of deferred procedures and expand access to minimally invasive care. The medical device maker slightly raised its adjusted gross profit margin forecast for 2025 to between 66% and 67% of revenue, up from earlier estimates of 65% to 66.5%. The updated range includes an estimated impact from tariffs of 1% of revenue, plus or minus 20 basis points, Intuitive said, compared to previously estimated impact of 1.7% of revenue, plus or minus 30 basis points. Shares of the Sunnyvale, California-based company fell 1.5% in after-hours trading. More than 80% of the instruments and accessories for the company's da Vinci system are produced at Intuitive's facility in Mexico, while the company also operates in China and other international markets. Intuitive's worldwide da Vinci procedure volumes rose about 17% compared to the same quarter last year. The company expects global da Vinci-assisted procedures to increase by about 15.5% to 17% in 2025, up from its prior forecast of 15% to 17%. On an adjusted basis, the medical device maker earned $2.19 per share for the quarter ended June 30, beating analysts' estimates of $1.92 per share, according to LSEG data. The company reported revenue of $2.44 billion for the second quarter, compared to analysts' estimates of $2.35 billion.
The Sun
07-07-2025
- Health
- The Sun
NHS to use robots on obese patients during surgery as it's safest way to operate on them
THE NHS will use surgical robots to get more fat Brits on the operating table because machines can work on people who are too high-risk for manual procedures. They use smaller instruments and enter through smaller incisions, and can be faster so patients do not need as much anaesthetic. 3 3 Robotics is one of the Government's 'five big bets' on technology that will revolutionise the NHS. Ministers' 10-Year Plan for the health service, launched last week, said it will 'expand surgical robot adoption'. NHS watchdog the National Institute for Health and Care Excellence (Nice) has encouraged hospitals to invest more in surgical robots and use them more widely. A recent report by NHS England added: 'Robot-assisted surgery may improve access to surgery for people who are at higher risk, including people with a high body mass index.' Body mass index is a height-to-weight ratio, with any number higher than 30 classed as obese. About three in 10 adults in England are obese and this puts them at higher risk during operations and may even mean they can't have them. Bulky fat means it takes longer to conduct super-precise surgery and large patients need more anaesthetic and lose more blood. Top prostate surgeon Ben Challacombe, who works at Guy's and St Thomas' NHS Trust in London, said: 'Operating on obese patients is highly complex and more tricky. 'When you're obese you're much more likely to get an infection or to have breathing difficulties because your lungs are being squashed by other tissues. 'Robotic assistance means we can do more. 'We can do robotic surgery on much bigger patients than we could with traditional keyhole surgery.' Jeffrey Ahmed, a gynaecological surgeon at Chelsea and Westminster NHS Trust, said: 'Some patients are too obese to have an operation, because to do a big open operation on someone whose BMI is 65 subjects them to too much risk. 'The minimally invasive approach that we can do on the robot opens up the possibility of doing that kind of care for patients. 'I think it will be used more in the future. 'If you can't physically do an operation for a patient without a robot, then that's going to be the way to do it. 'You can't just not offer the patient surgery because you don't have access to a robot.' Robot-assisted surgery relies on qualified surgeons controlling the £1m machines with the usual medical team around the patient. There are about 140 machines in use in England and their use has rocketed from 35,000 operations in 2022 to 70,000 in 2024. Dr Chris Smith-Brown, from the Private Healthcare Information Network, added: 'We know that losing weight is not always possible. 'There is hope that obesity won't have to be a barrier to life-changing surgery.' 3
